Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.

Int J Mol Sci · 2025 · PMC12428598 · PMID 40943144

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Data stratification analysis revealed a highly significant correlation between CD44 hi /CD24 lo -ALDH1 hi tumors and DFS and OS ( p < 0.001) in patients receiving neoadjuvant chemotherapy.

also in 132,142 other papers

showed a trendno p-value reported

CD10 did not correlate with any clinicopathological parameters, although it showed a trend of correlation with ER and PR negativity status, as previously reported [ 47 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44&lt;sup&gt;hi&lt;/sup&gt;/CD24&lt;sup&gt;lo&lt;/sup&gt;-ALDH1&lt;sup&gt;hi&lt;/sup&gt; as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.

The sentences

Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44<sup>hi</sup>/CD24<sup>lo</sup>-ALDH1<sup>hi</sup> as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.